Zhi Hong
Zhi Hong joined Tsinghua University and Third People’s Hospital of Shenzhen on March 31 to announce a partnership and license agreement to discover, develop, manufacture and commercialize fully human neutralizing monoclonal antibodies against COVID-19. The collaboration aims to achieve an accelerated six-month timeline from the selection of a lead development candidate to first-in-human clinical t...
N/A
Technology
N/A
Founded
N/A
Employees
N/A
Industry
Visual (Placeholder)
Profile Information
Name
Zhi Hong
Industry
N/A
Technology
N/A
Location
China
Founded
N/A
Employees
N/A
Category
Entrepreneurs
Contact Information
Email
N/A
Phone
N/A
Address
N/A